• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE; MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC ONE; MOZ Back to Search Results
Lot Number 7RSL021
Device Problem Microbial Contamination of Device (2303)
Patient Problems Arthralgia (2355); Joint Swelling (2356); No Code Available (3191)
Event Type  Injury  
Event Description
Major swelling [knee swelling], had to call out of work the next day [inability to work], pain [knee pain], device malfunction [device malfunction], possible sore throat but isn't positive [sore throat].Case narrative: initial information received on 05-jun-2018 regarding an unsolicited valid serious case received from the patient.Country: united states this case involves a (b)(6) male patient of (b)(6) who experienced major swelling, had to call out of work the next day, pain, device malfunction and possible sore throat (latency: unknown) while he was treated with hylan g-f 20, sodium hyaluronate (synvisc one).The patient's past medical history, medical treatment, vaccination and family history were not provided.In (b)(6) 2018, the patient took synvisc one dosage unknown (batch/lot number: 7rsl021; expiry date: unknown) in his left knee for product used for unknown indication.On the night of receiving his injection, patient developed major swelling (latency: unknown) which persisted for several days and lasted into weekend.It was reported that the patient had to call out of work the next day due to the swelling (latency: unknown).Also, the patient reported that his pain (latency: unknown) improved after his swelling went down.Patient had taken advil to help with the swelling but did not visit the hospital or the doctor's office for follow up.It was reported that the patient had a steroid injection and he did not do any walking or heavy lifting post synvisc-one injection.Patient also reported that he may had a possible sore throat but he wasn't positive (latency: unknown).Event of device malfunction (latency: unknown) was also reported since the synvisc one injection was from the recalled lot.It was reported by the patient that the knee that was injected with the synvisc-one contains hardware and whether he should be concerned.Final diagnosis was pain, possible sore throat but isn't positive, had to call out of work the next day, device malfunction and major swelling.A product technical complaint was initiated on 14-jun-2018 for synvisc one, batch number: 7rsl021, (b)(4).An investigation was initiated as a result of an unexpected increase in the number of labeled adverse events received from the us market for synvisc one lot 7rsl021.The product met all release testing at time of manufacture in june 2017.Retain samples were retested due to the unexpected increase in adverse events.Higher than expected endotoxin results were obtained.In addition, the presence of microbial contamination was also confirmed.The cause of these events is under investigation.Once this investigation is completed, corrective and preventive actions will be implemented.The patient outcome is reported as recovered/resolved for swelling.Recovering/resolving for pain.Unknown for had to call out of work the next day, device malfunction and possible sore throat but isn't positive.Follow up information received on 05-jun-2018 from patient.Consumer reported that the knee that was injected with synvisc-one contains hardware.Clinical course updated.Text amended accordingly.Additional information was received on 14-jun-2018.The global ptc number was added.Text was amended accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE
Type of Device
MOZ
Manufacturer (Section D)
GENZYME BIOSURGERY (RIDGEFIELD)
1125 pleasantview terrace
ridgefield NJ 07657
Manufacturer (Section G)
GENZYME BIOSURGERY (RIDGEFIELD)
1125 pleasantview terrace
ridgefield NJ 07657
Manufacturer Contact
darlene kadel
55 corporate drive, ms 55b-220
a
bridgewater, NJ 08807
MDR Report Key7925459
MDR Text Key122310410
Report Number2246315-2018-00623
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Remedial Action Recall
Type of Report Initial
Report Date 10/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number7RSL021
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Weight185
-
-